Follow
Oren Zusman
Oren Zusman
Senior Fellow, Department of Cardiology, Rabin Medical Center
Verified email at clalit.org.il
Title
Cited by
Cited by
Year
Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial
M Paul, GL Daikos, E Durante-Mangoni, D Yahav, Y Carmeli, YD Benattar, ...
The lancet Infectious diseases 18 (4), 391-400, 2018
5612018
Resting energy expenditure, calorie and protein consumption in critically ill patients: a retrospective cohort study
O Zusman, M Theilla, J Cohen, I Kagan, I Bendavid, P Singer
Critical care 20, 1-8, 2016
4092016
Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems
O Zusman, T Avni, L Leibovici, A Adler, L Friberg, T Stergiopoulou, ...
Antimicrobial agents and chemotherapy 57 (10), 5104-5111, 2013
2982013
Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis
O Zusman, S Altunin, F Koppel, Y Dishon Benattar, H Gedik, M Paul
Journal of Antimicrobial Chemotherapy 72 (1), 29-39, 2016
1922016
Predictive equations versus measured energy expenditure by indirect calorimetry: a retrospective validation
O Zusman, I Kagan, I Bendavid, M Theilla, J Cohen, P Singer
Clinical nutrition 38 (3), 1206-1210, 2019
1292019
Treatment Outcomes of Colistin- and Carbapenem-resistant Acinetobacter baumannii Infections: An Exploratory Subgroup Analysis of a Randomized Clinical Trial
Y Dickstein, J Lellouche, M Ben Dalak Amar, D Schwartz, A Nutman, ...
Clinical Infectious Diseases 69 (5), 769-776, 2019
1072019
The significance of new onset atrial fibrillation complicating acute myocardial infarction
O Zusman, G Amit, H Gilutz, D Zahger
Clinical Research in Cardiology 101, 17-22, 2012
762012
Colistin plus meropenem for carbapenem-resistant Gram-negative infections: in vitro synergism is not associated with better clinical outcomes
A Nutman, J Lellouche, E Temkin, G Daikos, A Skiada, ...
Clinical Microbiology and Infection 26 (9), 1185-1191, 2020
722020
Transcatheter aortic valve replacement in oncology patients with severe aortic stenosis
U Landes, Z Iakobishvili, D Vronsky, O Zusman, A Barsheshet, R Jaffe, ...
JACC: Cardiovascular Interventions 12 (1), 78-86, 2019
722019
Determinants of inappropriate empirical antibiotic treatment: systematic review and meta-analysis
E Carrara, I Pfeffer, O Zusman, L Leibovici, M Paul
International journal of antimicrobial agents 51 (4), 548-553, 2018
722018
Early administration of protein in critically ill patients: a retrospective cohort study
I Bendavid, O Zusman, I Kagan, M Theilla, J Cohen, P Singer
Nutrients 11 (1), 106, 2019
692019
The effectiveness and safety of high-dose colistin: prospective cohort study
YD Benattar, M Omar, O Zusman, D Yahav, Y Zak-Doron, S Altunin, ...
Clinical Infectious Diseases 63 (12), 1605-1612, 2016
622016
Impact of coronary artery revascularization completeness on outcomes of patients with coronary artery disease undergoing transcatheter aortic valve replacement: a meta-analysis …
G Witberg, O Zusman, P Codner, A Assali, R Kornowski
Circulation: Cardiovascular Interventions 11 (3), e006000, 2018
612018
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant …
Y Dickstein, L Leibovici, D Yahav, N Eliakim-Raz, GL Daikos, A Skiada, ...
BMJ open 6 (4), e009956, 2016
522016
Empirical antibiotic treatment does not improve outcomes in catheter-associated urinary tract infection: prospective cohort study
T Babich, O Zusman, M Elbaz, H Ben-Zvi, M Paul, L Leibovici, T Avni
Clinical Infectious Diseases 65 (11), 1799-1805, 2017
472017
Association between hypoalbuminemia and mortality among subjects treated with ertapenem versus other carbapenems: prospective cohort study
O Zusman, L Farbman, Z Tredler, V Daitch, A Lador, L Leibovici, M Paul
Clinical Microbiology and Infection 21 (1), 54-58, 2015
392015
Validation of carbon dioxide production (VCO2) as a tool to calculate resting energy expenditure (REE) in mechanically ventilated critically ill patients: a …
I Kagan, O Zusman, I Bendavid, M Theilla, J Cohen, P Singer
Critical Care 22, 1-6, 2018
382018
Intervention versus observation in symptomatic patients with normal flow low gradient severe aortic stenosis
O Zusman, GS Pressman, S Banai, A Finkelstein, Y Topilsky
JACC: Cardiovascular Imaging 11 (9), 1225-1232, 2018
382018
Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case–control study
N Eliakim-Raz, M Hellerman, D Yahav, J Cohen, I Margalit, S Fisher, ...
Journal of Antimicrobial Chemotherapy 72 (3), 882-887, 2017
362017
Transcatheter aortic valve implantation futility risk model development and validation among treated patients with aortic stenosis
O Zusman, R Kornowski, G Witberg, A Lador, K Orvin, A Levi, A Assali, ...
The American Journal of Cardiology 120 (12), 2241-2246, 2017
212017
The system can't perform the operation now. Try again later.
Articles 1–20